MAOB and Alzheimer disease: The kinetic studies determined thatcompound D39 exhibited noncompetitive inhibition of MAO-B.The activities of the target compounds were investigated using theDPPH antioxidant activity method to determine their oxidative stressprofiles in the context of AD.